In patients who experienced an acute coronary syndrome (ACS) event (such as heart attack or unstable angina), use of the drug darapladib to inhibit the enzyme lipoprotein-associated phospholipase A2 (believed to play a role ...
Aug 31, 2014
0
0
U.S. hospitalizations and deaths from heart disease and stroke dropped significantly in the last decade, according to new research in the American Heart Association journal Circulation.
Aug 18, 2014
0
0
In a recent study published in Tobacco Control, researchers at the University of Ottawa Heart Institute have demonstrated the cost-effectiveness of the Ottawa Model for Smoking Cessation (OMSC), an intervention that includes ...
Jun 18, 2014
0
0
The percentage of people reporting angina or chest pain dropped in the last two decades among Americans 65 and older and whites 40 and older—but not among blacks, according to a study in the American Heart Association journal ...
May 20, 2014
0
0
(Medical Xpress)—A new study, recently published in the leading international peer reviewed journal, The Journal of Emergency Medicine, has shown how a simple, individualised 40- minute educational session dramatically ...
May 2, 2014
0
0
Use of the drug aleglitazar, which has shown the ability to lower glucose levels and have favorable effects on cholesterol, did not reduce the risk of cardiovascular death, heart attack or stroke among patients with type ...
Mar 30, 2014
0
0
A new study indicates that in younger adults experiencing heart attacks and angina, men are more likely to receive faster care compared with women. The study, published in CMAJ (Canadian Medical Association Journal) also ...
Mar 17, 2014
0
0
(HealthDay)—The use of cardiac nuclear stress test agents comes with a rare but serious risk of heart attack and death, according to a warning sent by the U.S. Food and Drug Administration to health care professionals.
Nov 22, 2013
0
0
A team of doctor, patient and pharmacist plus enhanced follow-up was more effective than standard care in helping people take their heart medications more regularly after leaving the hospital, in a late-breaking clinical ...
Nov 19, 2013
0
0
Stephen J. Nicholls, M.B.B.S., Ph.D., of the South Australian Health and Medical Research Institute and University of Adelaide, Adelaide, Australia, and colleagues determined the effects of varespladib, a drug that inhibits ...
Nov 18, 2013
0
1
